| Tobradex Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Tobradex 0.1%-0.3% | suspension | ophthalmic | 100.0 milliliter(s) | OTC |
| Tobradex 0.1%-0.3% | suspension | ophthalmic | 100.0 milliliter(s) | OTC |
| Tobradex 0.1%-0.3% | ointment | ophthalmic | 100.0 gram(s) | OTC |
| Tobradex 0.1%-0.3% | ointment | ophthalmic | 100.0 gram(s) | OTC |
Posted by rcfgunkle 3 months ago
I experienced severe muscle pain in my shoulder and upper arms after using Tobradex for several days. I stopped the medicatio...
Posted by borny 8 months ago
I began to experience upper body itching (arms, back, and upper chest after taking TobraDex drops for two days. (perscription...
Posted by georgeclawson about 1 year ago
My eye infection has gotten a little red. I experienced light headedness along with mood swings. I'm not sure if I was reac...
Alcon Announces Leadership Change to Research and Development ... - Genetic Engineering News (press release)
... Vigamox(R) for bacterial conjunctivitis, TobraDex(R) for eye infections and inflammation, the AcrySof(R) line of intraocular lenses for cataract surgery ...
Mon Mar 10 11:44:01 -0400 2008
BAUSCH & LOMB ANNOUNCES POSITIVE CLINICAL RESULTS FOR ZYLET® - Eye-zine (press release)
Additionally, subjects treated with Tobradex experienced a significant increase in intraocular pressure (IOP) compared to those treated with Zylet. ...
Wed Feb 20 14:03:15 -0500 2008
Bausch & Lomb Announces Positive Clinical Results for Zylet in a ... - PharmaLive.com (press release)
Additionally, subjects treated with Tobradex experienced a significant increase in intraocular pressure (IOP) compared to those treated with Zylet. ...
Wed Feb 20 09:35:21 -0500 2008
dexamethasone - A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04)
tobramycin - The sulfate salt form of tobramycin, an aminoglycoside antibiotic derived from Streptomyces tenebrarius with bacteriostatic activity. Following active transport into the cell, tobramycin binds irreversibly to a specific aminoglycoside receptor on the bacterial 30S ribosomal subunit and interferes with the initiation complex between messenger RNA and the 30S subunit, thereby inhibiting initiation of protein synthesis, consequently leading to bacterial cell death. In addition, tobramycin induces misreading of the mRNA template causing incorrect amino acids to be incorporated into the growing polypeptide chain, consequently interfering with protein elongation.